Japan has begun surveying overseas arrivals about their COVID-19 vaccination status as it explores the feasibility of exempting those vaccinated abroad from the country’s strict entry restrictions, government sources said Tuesday.
While Japan has decided to issue so-called vaccine passports to enable residents who have been fully inoculated against the novel coronavirus to travel internationally, it has yet to ease border measures for holders of such vaccine certificates issued abroad.
But with more than 10 different vaccines used around the world, a number of issues remain to be resolved, including whether those not approved by the government will be recognized.
The Ministry of Health, Labor and Welfare has been asking overseas arrivals quarantining at facilities to fill in voluntary questionnaires since early July, the sources said.
The questionnaires, based on self-reporting with no proof required, ask whether individuals have received any doses of COVID-19 vaccine, including those not currently approved in Japan, and if 14 days have elapsed since their last shot.
Japan has so far approved vaccines developed by U.S. pharmaceutical companies Pfizer Inc. and Moderna Inc. as well as Britain’s AstraZeneca PLC.
The government plans to use the responses to its survey in conjunction with other data, such as each vaccine’s efficacy, to determine whether border measures can be eased in the future.
According to the Immigration Services Agency, around 43,000 Japanese nationals and 17,000 foreign nationals entered the country in June.
The need for arrivals to quarantine in accommodation facilities has become a huge burden for them and health authorities, with some officials of the opinion that it “cannot continue indefinitely.”
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.